Evaluation of the Ulthera System for the Treatment of the Decolletage

Inclusion Criteria: * Female, aged 35 to 70 years. * Subject in good health. * Moderate to severe skin lines and wrinkles on the décolletage; grade of ≥4 on a chest wrinkle scale. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. * Willingness and ability to comply with protocol requirements. * Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating. * Absence of physical conditions unacceptable to the investigator. * Willingness and ability to provide written consent for study-required photography. * Willingness and ability to provide written informed consent. Exclusion Criteria: * Presence of an active systemic or local skin disease that may affect wound healing. * Scarring in areas to be treated. * Tattoos in the areas to be treated. * Patients with ports or defibrillators. * Any open wounds or lesions in the area. * Active and severe inflammatory acne in the region to be treated. * Patients who have a history with keloid formation or hypertrophic scarring. * Inability to understand the protocol or to give informed consent. * Retinoid, microdermabrasion, or prescription level glycolic acid treatments to the décolletage area within two weeks prior to study participation or during the study. * Marked décolletage asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin. * History of chronic drug or alcohol abuse. * History of autoimmune disease. * Concurrent therapy that would interfere with the evaluation of the safety or effectiveness of the study device. * Subjects who anticipate the need for surgery or overnight hospitalization during the study. * Subjects who have a history of poor cooperation, noncompliance with medical treatment, or unreliability. * Concurrent enrollment in any study involving the use of investigational devices or drugs. * Current smoker or history of smoking in the last one year. * History of using the following prescription medications: 1. Topical Retinoids to the area within the past two weeks; 2. Antiplatelet agents/anticoagulants (Coumadin, Heparin, Plavix). 3. Psychiatric drugs that would impair the subject from understanding the protocol requirements or understanding and signing the informed consent.